Searched for
HAMIED CIPLA
Cipla shares in focus as promoters Samina and Rumana Hamied offload 1.72% stake for Rs 2,111 croreCipla shares are in focus today after Samina Hamied and Rumana Hamied, promoters of the pharmaceutical company, exited by selling their 1.7...- Promoters Samina and Rumana Hamied exit Cipla; sell 1.72 pc stake for Rs 2,111 croreSamina Hamied and Rumana Hamied, promoters of drug major Cipla, on Monday exited the pharmaceutical company by selling their 1.72 per cent ...
- Cipla's vice-chairman MK Hamied resigns citing age and health, his son Kamil to join the boardCipla's vice-chairman MK Hamied has resigned from the board due to age and health concerns, effective October 29, 2024. His son Kamil Hamie...
- Cipla's MK Hamied resigns from the company due to health reasonsCipla's Vice Chairman and Non-Executive Director, Mr. M K Hamied, has resigned from his position due to age and health reasons. His resigna...
- Cipla promoters sell 2.53% stake for Rs 2,751 crore"Post transaction, the entire promoter group, including persons acting in concert, continues to hold 31.67% in the company and remains comm...
- Samina Hamied of Cipla steps down from her executive roleSamina Hamied, executive vice-chairperson of Cipla, announced her decision to step down from her executive role due to personal and family ...
- Samina Hamied to step down as Cipla executive vice chairpersonDrug major Cipla on Thursday said Samina Hamied has decided to step down from the position of Executive Vice Chairperson of the company, wh...
- Cipla founding family’s stake sale in jeopardy over $13 billion valuation targetProspective buyers of a stake in Indian pharmaceutical company Cipla Ltd. are hesitant due to the high valuation demanded by the founding f...
- Epic saga of Cipla: How a swadeshi Robin Hood took on Big Pharma of the WestCipla has been closely associated with India's struggle for independence, with Khwaja Abdul Hamied forming the company in 1935. For the Big...
- Pills to wellness, Cipla is seeking a new identityOne of the major successes of Hamied was building a strong US business, despite Cipla being a late entrant. Hamied said this was made possi...
- Pills to wellness, Cipla is seeking a new identityOne of the major successes of Hamied was building a strong US business, despite Cipla being a late entrant. Hamied said this was possible b...
- ET Businesswoman of the Year 2021: Samina Hamied - The woman who carries forward a storied legacy, seeking profit, but never at the cost of values“I am humbled and honoured to receive the ET’s Businesswoman of the Year Award. This recognition belongs to each and every one of our 25,00...
- Collaborating with government agencies to develop treatment for COVID-19: CiplaBesides scaling up production of medicines that show potency against the virus -- Lopinavir + Ritonavir, Hydroxychloroquine and Azithromyci...
- A perfect throwback birthday celebration for YK Hamied, Chairman, CiplaHamied celebrated his 81st birthday last week.
- Cipla names Samina Vaziralli as Executive Vice-ChairmanVaziralli, daughter of MK Hamied -- the company's non-executive VC - has been a part of the core leadership team since joining the Mumbai-b...
- YK Hamied to increase stake in Cipla to over 20 per centCipla patriarch YK Hamied plans to increase his holding to over 20 per cent by acquiring over 5 per cent additional stake in the homegrown ...
- Cipla inducts Samina Vaziralli, chairman YK Hamied's niece to company's boardSamina Vaziralli, niece of Cipla Chairman YK Hamied, was appointed to the company's board on Thursday, thus inducting the next generation.
- Need continuity in policies for pharma sector: YK Hamied, CiplaNow if you look at the world’s top 70 drugs, 50% of them or more are made and marketed by companies that did not invent them.
- Don't look now, Cipla just might be changing, says Cipla chairman & MD Dr Yusuf HamiedET delves into why one of India's oldest and best-known pharma companies is taking a hard look at itself.
- Cipla promoters not selling out,Co plans to scale up revenuesPharma major Cipla on Thursday said it is expecting to scale up its revenue by over six times to Rs 15,000-20,000 crore.
Load More
